Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Response Rate”

532 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 532 results

Testing effectiveness (Phase 2)UnknownNCT00568607
What this trial is testing

Study on the Combination Regimen of Dexamethasone Ifosfamide Cisplatin Etoposide in Patients With NK/T Cell Lymphoma

Who this might be right for
Lymphoma
Fudan University 60
Not applicableUnknownNCT00449319
What this trial is testing

AML Treatment in Untreated Adult Patients

Who this might be right for
Leukemia, Myelocytic, Acute
Gruppo Italiano Malattie EMatologiche dell'Adulto
Not applicableStudy completedNCT03071952
What this trial is testing

Assessment of AAIR Pacing Treatment for Heart Failure Patients With Chronotropic Incompetence

Who this might be right for
Heart Failure
Medtronic Cardiac Rhythm and Heart Failure 11
Post-approval studies (Phase 4)Study completedNCT01429792
What this trial is testing

A Study Evaluating Slow Response/Non-Rapid Response in Patients With Chronic Hepatitis C, Genotype 1, 2, 3 & 4 Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 1,013
Testing effectiveness (Phase 2)Study completedNCT01893372
What this trial is testing

Eltrombopag With or Without Hypomethylating Agent After Hypomethylating Agent Failure For Patients With Myelodysplastic Syndrome (MDS)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 29
Not applicableNot Yet RecruitingNCT07312409
What this trial is testing

Does Taurine Supplementation Improve Vascular Function and Orthostatic Responses in Long COVID?

Who this might be right for
Long COVID Syndrome
York University 30
Testing effectiveness (Phase 2)Study completedNCT01227707
What this trial is testing

Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer.

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 43
Testing effectiveness (Phase 2)Ended earlyNCT00517699
What this trial is testing

MabThera (Rituximab) in Primary Central Nervous System Lymphoma.

Who this might be right for
Lymphoma
Hoffmann-La Roche 5
Not applicableStudy completedNCT05092672
What this trial is testing

Physical Activity, Air Pollution, and High Blood Pressure

Who this might be right for
Essential Hypertension
University of British Columbia 21
Testing effectiveness (Phase 2)Ended earlyNCT00493025
What this trial is testing

Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery

Who this might be right for
Esophageal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Ended earlyNCT01466868
What this trial is testing

Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
Centre Leon Berard 22
Not applicableStudy completedNCT04967235
What this trial is testing

Dance Therapy as an Alternative for Cardiac Rehabilitation in Women Population

Who this might be right for
Cardiac Risk FactorsCardiovascular Diseases
Universidade Estadual Paulista Júlio de Mesquita Filho 20
Not applicableWithdrawnNCT03160625
What this trial is testing

Evaluation of Rate Adaptive Pacing on Chronotropic Response in Preserved Ejection Fraction HF

Who this might be right for
Heart Failure With Preserved Ejection Fraction
Medtronic Cardiac Rhythm and Heart Failure
Testing effectiveness (Phase 2)Study completedNCT06592547
What this trial is testing

Intravenous Metoprolol in Septic Shock

Who this might be right for
Septic ShockVentilator Acquired Pneumonia
Alexandria University 100
Not applicableNot Yet RecruitingNCT07475338
What this trial is testing

Effect of Storytelling on Questionnaire Completion and Quality of Collected Data in an E-Cohort

Who this might be right for
General Population (no Specific Condition or Disease)
SKEZI 500
Testing effectiveness (Phase 2)Looking for participantsNCT06125834
What this trial is testing

Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Progressive Disease After TKIs or HP Therapy

Who this might be right for
Advanced Breast CancerObjective Response RateTrastuzumab Emtansine
The First Affiliated Hospital with Nanjing Medical University 36
Large-scale testing (Phase 3)Study completedNCT00596206
What this trial is testing

Leflunomide EfficAcy Response Related to Dosing Regimen in Early Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Sanofi 124
Post-approval studies (Phase 4)Looking for participantsNCT04588077
What this trial is testing

Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis

Who this might be right for
Hepatitis BCirrhosis, LiverChronic Liver Disease
Mercy Medical Center 200
Post-approval studies (Phase 4)Ended earlyNCT02203630
What this trial is testing

Phenylephrine Versus Norepinephrine for Septic Shock in Critically Ill Patients

Who this might be right for
Septic ShockSepsisShock+2 more
Vanderbilt University Medical Center 17
Post-approval studies (Phase 4)Study completedNCT01227577
What this trial is testing

CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib

Who this might be right for
Chronic Myelogenous Leukemia in Chronic Phase
Novartis Pharmaceuticals 128
Load More Results